Potential Application of Chimeric Antigen Receptor (CAR)-T Cell Therapy in Renal Cell Tumors

Currently, renal cell carcinoma is characterized by encouraging benefits from immunotherapy that have led to significant results in treatment outcome. The approval of nivolumab primarily as second-line monotherapy and, more recently, the approval of new combination therapies as first-line treatment...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Front Oncol
Hlavní autoři: Schepisi, Giuseppe, Conteduca, Vincenza, Casadei, Chiara, Gurioli, Giorgia, Rossi, Lorena, Gallà, Valentina, Cursano, Maria Concetta, Brighi, Nicole, Lolli, Cristian, Menna, Cecilia, Farolfi, Alberto, Burgio, Salvatore Luca, Altavilla, Amelia, Martinelli, Giovanni, De Giorgi, Ugo
Médium: Artigo
Jazyk:Inglês
Vydáno: Frontiers Media S.A. 2020
Témata:
Oncology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7538692/
https://ncbi.nlm.nih.gov/pubmed/33072597
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.565857
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky